YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
97 hedge funds and large institutions have $716M invested in Y-mAbs Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 41 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-3
Holders Change %
-3%
% of All Funds
1.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
41
Reduced
29
Closed
13
Calls
–
Puts
$665K
Net Calls
-$665K
Net Calls Change
-$665K
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$10.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.81M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.58M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.46M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$3.3M |
